Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

Wen, Patrick Y, Weller, Michael, Lee, Eudocia Quant, Alexander, Brian M, Barnholtz-Sloan, Jill S, Barthel, Floris P, Batchelor, Tracy T, Bindra, Ranjit S +32 more·2020·Neuro-Oncology

DOI 10.1093/neuonc/noaa106

Cited by (1,000)

Items 301–400 of 1,000

Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma
Crismita Dmello, Andrew Jacob Brenner, David Eric Piccioni, Patrick Yung Wen, Jan Drappatz, Maciej M. Mrugala, Lionel D. Lewis, David Schiff, Camilo E. Fadul, Marc Charles Chamberlain et al. · 2024 · Neuro-Oncology Advances
A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis
Julie Bennett, Adrian Levine, Liana Figueiredo Nobre, Logine Negm, Jiil Chung, Karen Fang, Monique Johnson, Martin Komosa, Stacey L. Krumholtz, Nuno Miguel Nunes et al. · 2025 · Nature Cancer
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety
Michael E. Barish, Maryam Aftabizadeh, Jonathan C. Hibbard, M. Suzette Blanchard, Julie R. Ostberg, Jamie R. Wagner, Mishika Manchanda, Jinny A. Paul, Tracy Stiller, Brenda Aguilar et al. · 2025 · Cell Reports Medicine
The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents
Sebastian Siller, Michael Lauseker, Philipp Karschnia, Maximilian Niyazi, Sabina Eigenbrod, Armin Giese, Joerg‐Christian Tonn · 2021 · Acta Neuropathologica Communications
Endocannabinoid signaling in glioma
Carlos Costas‐Insua, Manuel Guzmán · 2022 · Glia
Disruption of β-catenin-mediated negative feedback reinforces cAMP-induced neuronal differentiation in glioma stem cells
Zhijie Chen, Yingqian Zhong, Jiehong Chen, Shuxin Sun, Wenfeng Liu, Yu Han, Xincheng Liu, Cui Guo, De‐Pei Li, Wanming Hu et al. · 2022 · Cell Death and Disease
Surgery of Motor Eloquent Glioblastoma Guided by TMS-Informed Tractography: Driving Resection Completeness Towards Prolonged Survival
Carolin Weiß Lucas, Andrea Maria Faymonville, Ricardo Loução, Catharina Schröter, Charlotte Nettekoven, Ana‐Maria Oros‐Peusquens, Karl‐Josef Langen, Nadim Jon Shah, Gabriele Stoffels, Volker Neuschmelting et al. · 2022 · Frontiers in Oncology
Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma
Hui-Ju Tseng, Suddhasatwa Banerjee, Bin Qian, Mei-Jung Lai, Tung-Yun Wu, Tsung‐I Hsu, Tony Eight Lin, Kai‐Cheng Hsu, Kuo‐Hsiang Chuang, Jing‐Ping Liou et al. · 2023 · European Journal of Medicinal Chemistry
Multi‐omic integration of DNA methylation and gene expression data reveals molecular vulnerabilities in glioblastoma
Pablo Santamarina‐Ojeda, Juan Ramón Tejedor, Raúl F. Pérez, Virginia López, Annalisa Roberti, Cristina Mangas, Agustín F. Fernández, Mario F. Fraga · 2023 · Molecular Oncology
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022
Christoph Oster, Teresa Schmidt, Sarina Agkatsev, Lazaros Lazaridis, Christoph Kleinschnitz, Ulrich Sure, Björn Scheffler, Sied Kebir, Martin Glas · 2023 · Neuro-Oncology Advances
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review
Ashray Gunjur, Adithya Balasubramanian, Umbreen Hafeez, Siddharth Menon, Lawrence Cher, Sagun Parakh, Hui Kong Gan · 2022 · Journal of Neuro-Oncology
Nanoparticles for Glioblastoma Treatment
Dorota Bartusik‐Aebisher, Kacper Rogóż, David Aebisher · 2025 · Pharmaceutics
Current status of precision oncology in adult glioblastoma
Johannes M Weller, Anna‐Laura Potthoff, Thomas Zeyen, Christina Schaub, Cathrina Duffy, Matthias B. Schneider, Ulrich Herrlinger · 2024 · Molecular Oncology
Blood coagulation and cancer genes
Nadim Tawil, Janusz W. Rak · 2022 · Best Practice & Research Clinical Haematology
Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis
James Stewart, Arjun Sahgal, Aimee Chan, Hany Soliman, Chia‐Lin Tseng, Jay S. Detsky, Sten D. Myrehaug, Eshetu G. Atenafu, Ali Helmi, James Perry et al. · 2022 · Technology in Cancer Research & Treatment
Current therapeutic options for glioblastoma and future perspectives
Elisa Aquilanti, Patrick Yung Wen · 2022 · Expert Opinion on Pharmacotherapy
Analyzing the role of reoperation in recurrent glioblastoma: a 15-year retrospective study in a single institution
Víctor González Jiménez, Marta Brell, José Fuster, Lesmes Moratinos, Daniel Alegre, Sofía López, Javier Ibáñez · 2022 · World Journal of Surgical Oncology
Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma
Stephen Ahn, Jae‐Sung Park, Heewon Kim, Minkyu Heo, Young Chul Sung, Sin‐Soo Jeun · 2022 · Cancer Medicine
The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma
Ran Li, Haiyan Chen, Chaoxi Li, Yiwei Qi, Kai Zhao, Junwen Wang, Chao You, Haohao Huang · 2023 · BMC Bioinformatics
Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment
John Lattier, Arpan De, Zhihua Chen, John E. Morales, Frederick F. Lang, Jason T. Huse, Joseph H. McCarty · 2020 · Oncogene
Status Quo and Trends of Intra-Arterial Therapy for Brain Tumors: A Bibliometric and Clinical Trials Analysis
Julian S. Rechberger, Frederic Thiele, David J. Daniels · 2021 · Pharmaceutics
Radiogenomic Predictors of Recurrence in Glioblastoma—A Systematic Review
Felix Corr, Dustin Grimm, Benjamin Saß, Mirza Pojskić, Jörg Walter Bartsch, Barbara Carl, Christopher Nimsky, Miriam H. A. Bopp · 2022 · Journal of Personalized Medicine
Discovery of N-Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma
Guangwei Cui, Yuhang Fan, Yue Yang, Yiwen Ma, Haiyang Deng, Pan Wang, Yuxin Zhu, Jian Li, Jinlian Wei, Yongqiang Zhang · 2024 · Journal of Medicinal Chemistry
Correlation of Intraoperative 5-ALA-Induced Fluorescence Intensity and Preoperative 11C-Methionine PET Uptake in Glioma Surgery
K. Shimizu, Kaoru Tamura, Shoko Hara, Motoki Inaji, Yoji Tanaka, Daisuke Kobayashi, Takashi Sugawara, Hiroaki Wakimoto, Tadashi Nariai, Kenji Ishii et al. · 2022 · Cancers
Notch signaling in malignant gliomas: supporting tumor growth and the vascular environment
Franciele Cristina Kipper, Mark W. Kieran, Ajith J. Thomas, Dipak Panigrahy · 2022 · Cancer and Metastasis Reviews
Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth
Asimina Zisi, Dimitris C. Kanellis, Simon Moussaud, Ida Karlsson, Helena Carén, Lars Bräutigam, Jiří Bártek, Mikael S. Lindström · 2022 · Neuro-Oncology
Selection of potential natural compounds for poly-ADP-ribose polymerase (PARP) inhibition in glioblastoma therapy by in silico screening methods
Arunraj Tharamelveliyil Rajendran, Gupta Dheeraj Rajesh, Pankaj Kumar, Prarambh S. R. Dwivedi, Chakrakodi Shashidhara Shastry, Anoop Narayanan Vadakkepushpakath · 2023 · Saudi Journal of Biological Sciences
Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA
Hermes Paraqindes, Nour‐El‐Houda Mourksi, Samantha Ballesta, Jordan Hedjam, Fleur Bourdelais, Tanguy Fenouil, Thiébaud Picart, Frédéric Catez, Théo Combe, Anthony Ferrari et al. · 2023 · Neuro-Oncology
Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era
Ari D. Kappel, Rohan Jha, Saibaba Guggilapu, W. J. Bernhard Smith, Abdullah Hamid Feroze, Adam Andrew Dmytriw, Juan C. Vicenty‐Padilla, Rodolfo E. Alcedo Guardia, Florian A Gessler, Nirav J. Patel et al. · 2024 · Cancers
Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis
Guangzhong Guo, Ziyue Zhang, Jiubing Zhang, Dayang Wang, Sensen Xu, Guanzheng Liu, Yushuai Gao, Jie Mei, Zhaoyue Yan, Zhao Ruijiao et al. · 2024 · Cancer Immunology Immunotherapy
Understanding serine and glycine metabolism in cancer: a path towards precision medicine to improve patient’s outcomes
Anaís Sánchez‐Castillo, Kim Rosalie Kampen · 2024 · Discover Oncology
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
Bryan J. Neth, Mason Webb, Ian F. Parney, Ugur T. Sener · 2023 · Pharmaceutics
The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas
Anudeep Yekula, Abigail Taylor, Alexandra Beecroft, Keiko M. Kang, Julia L. Small, Koushik Muralidharan, Zachary S. Rosh, Bob S. Carter, Leonora Balaj · 2020 · Cancer Drug Resistance
Classification of glioma grade and Ki-67 level prediction in MRI data: A SHAP-driven interpretation
Enamul Bhuiyan, Muntakim Mahmud Khan, Md. Sakib Abrar Hossain, R. Rahman, Q. Luo, M.F. Hossain, K. Wang, Md. Shaheenur Islam Sumon, Syed Ibad Khalid, M. Karaman et al. · 2025 · Computerized Medical Imaging and Graphics
Feasibility of glioblastoma tissue response mapping with physiologic BOLD imaging using precise oxygen and carbon dioxide challenge
Vittorio Stumpo, Martina Sebök, Christiaan Hendrik Bas van Niftrik, Katharina Seystahl, Nicolin Hainc, Zsolt Kulcsár, Michael Weller, Luca Regli, Jorn Fierstra · 2021 · Magnetic Resonance Materials in Physics Biology and Medicine
ASCL2 Maintains Stemness Phenotype through ATG9B and Sensitizes Gliomas to Autophagy Inhibitor
Lihong Wang, Ye Yuan, Jiao Wang, Ying Luo, Yang Lan, Jia Ge, Lei Li, Feng Liu, Qing Deng, Zexuan Yan et al. · 2022 · Advanced Science
Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab
Caroline Hertler, Katharina Seystahl, Émilie Le Rhun, Hans‐Georg Wirsching, Patrick Roth, Michael Weller, Dorothee Gramatzki · 2022 · Neuro-Oncology
Combined anti-C1-INH and radiotherapy against glioblastoma
Emma Liljedahl, Elise Konradsson, Emma Gustafsson, Karolina Förnvik, Jill K. Olofsson, Kurt Osther, Crister P Ceberg, Henrietta Nittby Redebrandt · 2023 · BMC Cancer
A transformer-based multi-task deep learning model for simultaneous infiltrated brain area identification and segmentation of gliomas
Yin Li, Kaiyi Zheng, Shuang Li, Yongju Yi, Min Li, Yufan Ren, Congyue Guo, Liming Zhong, Wei Yang, Xinming Li et al. · 2023 · Cancer Imaging
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial
Émilie Le Rhun, Thierry Gorlia, Jörg Felsberg, Joost L.M. Jongen, Claude‐Alain Maurage, François Ducray, Dorothee Gramatzki, Peter Hau, Olivier Louis Chinot, Matthias Preusser et al. · 2023 · European Journal of Cancer
An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma
Alberto Reale, Andrea Gatta, Amruth K B Shaik, Mariam Shallak, Anna Maria Chiaravalli, Michele Cerati, Martina Zaccaria, Stefano La Rosa, Arianna Calistri, Roberto Sergio Accolla et al. · 2024 · Journal of Translational Medicine
Glioblastoma multiforme - a rare type of cancer: A narrative review
Gaurvi Bijalwan, Abhishek Kumar Shrivastav, Sarita Mallik, Manish Kumar Dubey · 2024 · Cancer Research Statistics and Treatment
Hunting glioblastoma recurrence: glioma stem cells as retrospective targets
Sümeyra Mengüç Emir, Birnur Sinem Karaoglan, Ramazan Kaşmer, Hilal Buse Şirin, Batuhan Sarıyıldız, Nihal Karakaş · 2025 · American Journal of Physiology-Cell Physiology
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models
Miaomiao Sun, Maciej Białasek, Maud Mayoux, Meng-Syuan Lin, Alicia Buck, Ilona Marszałek, Bartłomiej Taciak, Marcel Bühler, Małgorzata Górczak, Paulina Kucharzewska et al. · 2025 · Science Translational Medicine
Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity
Elisabete Cruz Da Silva, Sophie Foppolo, Benoît Lhermitte, Marina Ingremeau, Hélène Justiniano, Lorraine Klein, Marie‐Pierre Chenard, Romain Vauchelles, Basma Abdallah, Maxime Lehmann et al. · 2022 · Pharmaceutics
Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature
Gabrielle Arbour, Benjamin Ellezam, Alexander Gregory Weil, Romain Cayrol, Magimairajan Vanan, Hallie Coltin, Valérie Larouche, Craig Alexander Erker, Nada Jabado, Sébastien Perreault · 2022 · Neuro-Oncology Advances
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement
Angela Jae Waanders, Alex D. H. Brown, Nadine R. Caron, Alexa Plisiewicz, Sean McHugh, Thinh Nguyen, Kaitlin Lehmann, Jeffrey Stevens, Phillip Storm, Adam Cain Resnick et al. · 2023 · Neoplasia
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience
Sarah M. Trinder, Campbell McKay, Phoebe Power, Monique D. Topp, Bosco Chan, Santosh Valvi, Geoffrey Brian McCowage, Dinisha Govender, Maria L. Kirby, David Simon Ziegler et al. · 2023 · Frontiers in Oncology
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
Giacomo Sferruzza, Stefano Consoli, Fedele Dono, Giacomo Evangelista, Alessia Giugno, Edoardo Pronello, Eleonora Rollo, Marina Romozzi, Lucrezia Rossi, Umberto Pensato · 2024 · Neurological Sciences
Protoporphyrin IX in serum of high-grade glioma patients: A novel target for disease monitoring via liquid biopsy
Anna Walke, Christopher Krone, Walter Stummer, Simone König, Eric Suero Molina · 2024 · Scientific Reports
ROR1 facilitates glioblastoma growth via stabilizing GRB2 to promote c-Fos expression in glioma stem cells
Hongtao Zhu, Lidong Cheng, Dan Liu, Xiaoyu Ma, Zhiye Chen, Heng Fan, Ran Li, Yang Zhang, Hailong Mi, Jun Li et al. · 2024 · Neuro-Oncology
Selective induction of rapid cytotoxic effect in glioblastoma cells by oscillating magnetic fields
Santosh A. Helekar, Shashank Hambarde, Omkar B. Ijare, Kumar Pichumani, David S. Baskin, Martyn A. Sharpe · 2021 · Journal of Cancer Research and Clinical Oncology
Practical guidance for telemedicine use in neuro-oncology
Roy Ervin Strowd III, Erin M Dunbar, Hui Kong Gan, Sylvia Christine Kurz, Justin T. Jordan, Jacob Joseph Mandel, Nimish A. Mohile, Kathryn Sara Nevel, Jennie Webster Taylor, Nicole J. Ullrich et al. · 2022 · Neuro-Oncology Practice
Long-term survival, patterns of progression, and patterns of use for patients with newly diagnosed glioblastoma treated with or without Tumor Treating Fields (TTFields) in a real-world setting
Devon C. Riegel, Britta Lynn Bureau, Patrick Conlon, Gordon Vincent Chavez, Jennifer Connelly · 2025 · Journal of Neuro-Oncology
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Yung Wen, Donald A. Berry, Meredith Buxton, Howard Colman, John de Groot, Michael K. Lim, Ingo K. Mellinghoff, James R. Perry, Michael Weller, Nicolas Blondin et al. · 2026 · Journal of Clinical Oncology
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
Johanna Heugenhauser, Malik Galijašević, Stephanie Mangesius, Georg Goebel, Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Georg Widhalm, Günther Stockhammer, Sarah Iglseder et al. · 2022 · Cancers
Simultaneous determination of LY3214996, abemaciclib, and M2 and M20 metabolites in human plasma, cerebrospinal fluid, and brain tumor by LC-MS/MS
Tigran Margaryan, Mackenna Elliott, Nader Sanai, Artak G. Tovmasyan · 2022 · Journal of Pharmaceutical Analysis
The eIF4A Inhibitor Silvestrol Blocks the Growth of Human Glioblastoma Cells by Inhibiting AKT/mTOR and ERK1/2 Signaling Pathway
Wei Zhang, Pian Gong, Qi Tian, Shoumeng Han, Jianfeng Wang, Peibang He, Yujia Guo, Guijun Wang, Qianxue Chen, Jie Huang et al. · 2022 · Journal of Oncology
Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response
Yonghua Cai, Ke Li, Jie Lin, Xianqiu Liang, Wei Xu, Zhengming Zhan, Shuaishuai Xue, Yu Zeng, Peng Chai, Yangqi Mao et al. · 2022 · Frontiers in Immunology
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors
Ahmed M. Elshazly, David A. Gewirtz · 2023 · International Journal of Molecular Sciences
Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives
Alberto Pïcca, Giulio Sansone, Orazio Santo Santonocito, Chiara Maria Mazzanti, Marc Sanson, Anna Luisa Di Stefano · 2023 · Cancers
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival
D. Feucht, P. Haas, M. Skardelly, F. Behling, D. Rieger, P. Bombach, F. Paulsen, E. Hoffmann, Till-Karsten Hauser, B. Bender et al. · 2024 · Neuro-Oncology Advances
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers
Helene Damhofer, Tülin Tatar, Benjamin Southgate, Scott A. Scarneo, Karl Agger, Daria Shlyueva, Lene Uhrbom, Gillian M. Morrison, Philip F. Hughes, Timothy Haystead et al. · 2024 · Cell Death and Disease
Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles
Soo Yeon Kim, Miaolu Tang, Tong Lu, Stephen Y. Chih, Wei Li · 2024 · Brain Research
Chlorotoxin-functionalized mesoporous silica nanoparticles for pH-responsive paclitaxel delivery to Glioblastoma multiforme
Mirjana Mundžić, Amelia Ultimo, Minja Mladenović, Aleksandra Pavlović, Oliviero L. Gobbo, Eduardo Ruiz‐Hernández, Maria José Santos-Martínez, Nikola Ž. Knežević · 2024 · Heliyon
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types
Arnaud Beddok, Jonas Willmann, Anna Embring, Ane Lindegaard Appelt, Panagiotis Balermpas, Kevin Chua, J. Isabelle Choi, Bernice S. Elger, Dorota Gabryś, Peter Hoskin et al. · 2025 · CA A Cancer Journal for Clinicians
Radiotherapy for Newly Diagnosed Glioblastoma in the Elderly: What Is the Standard?
Chan Woo Wee · 2022 · Brain Tumor Research and Treatment
HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion
Tao Li, Farideh Mehraein‐Ghomi, M. Elizabeth Forbes, Sanjeev V. Namjoshi, Elizabeth A. Ballard, Qianqian Song, Ping‐Chieh Chou, Xuya Wang, Brittany C. Parker Kerrigan, Frederick F. Lang et al. · 2022 · Molecular Therapy
Socioeconomic factors affecting survivorship of glioblastoma patients in the Philippines
Manilyn Ann C. Hong, Abdelsimar Tan Omar, Kathleen Joy O. Khu · 2022 · Journal of Clinical Neuroscience
The impact of temozolomide and lonafarnib on the stemness marker expression of glioblastoma cells in multicellular spheroids
Pinaki S. Nakod, Raghu Vamsi Kondapaneni, Brandon Edney, Yonghyun Kim, Shreyas S. Rao · 2022 · Biotechnology Progress
Managing Side Effects of Cytotoxic Chemotherapy in Patients With High Grade Gliomas
Hyerim Ha, Joo Han Lim · 2022 · Brain Tumor Research and Treatment
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma
Lazaros Lazaridis, Elisabeth Bumes, Dorothee Cäcilia Spille, Tim Schulz, Sina Heider, Sarina Agkatsev, Teresa Schmidt, Tobias Blau, Christoph Oster, Jonas Feldheim et al. · 2022 · Neuro-Oncology Advances
Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline
Mary Jane Lim-Fat, Maria MacDonald, Sarah Lapointe, Seth Climans, Chantel Cacciotti, Manik Chahal, Sébastien Perreault, Derek S. Tsang, Andrew F. Gao, Stephen S. F. Yip et al. · 2022 · Frontiers in Oncology
Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation
Vincent Fougner, Benedikte Hasselbalch, Ulrik Lassen, Joachim Weischenfeldt, Hans Skovgaard Poulsen, Thomas Haargaard Urup · 2022 · Neuro-Oncology Advances
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity
Jamie Dean, Shyam Kumar Tanguturi, Daniel N. Cagney, Kee‐Young Shin, Gilbert Youssef, Ayal Aaron Aizer, Rifaquat M. Rahman, Lubna Hammoudeh, David A. Reardon, Eudocia Q. Lee et al. · 2022 · Neuro-Oncology
Multireceptor targeting of glioblastoma
Puja Sharma, Poonam Sonawane, Denise Herpai, Ralph D’Agostino, John Henry Rossmeisl, Stephen B. Tatter, Waldemar Debinski · 2020 · Neuro-Oncology Advances
Fast‐field‐cycling NMR at very low magnetic fields: water molecular dynamic biomarkers of glioma cell invasion and migration
Manuel Petit, Maxime Leclercq, Sandra Pierre, Maria Rosaria Ruggiero, Michèle El Atifi, Jean Boutonnât, Pascal Henry Fries, François R. Berger, Hana Lahrech · 2021 · NMR in Biomedicine
Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response
Haipeng Tao, Dongjiang Chen, Changlin Yang, Duy Nguyen, Georges Abboud, Ruixuan Liu, Tianyi Liu, Avirup Chakraborty, Alicia Y. Hou, Nicole A Petit et al. · 2025 · Journal of Clinical Investigation
Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma
Otto Mølby Henriksen, Adam Espe Hansen, Aida Muhic, Lisbeth Marner, Karine Madsen, Søren Møller, Benedikte Hasselbalch, Michael Juncker Lundemann, David Scheie, Jane Skjøth‐Rasmussen et al. · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
Patterns of gray and white matter functional networks involvement in glioblastoma patients: indirect mapping from clinical MRI scans
Giulio Sansone, Lorenzo Pini, Alessandro Salvalaggio, Matteo Gaiola, Francesco Volpin, Valentina Baro, Marta Padovan, Mariagiulia Anglani, Silvia Facchini, Franco Chioffi et al. · 2023 · Frontiers in Neurology
The Role of Bacteria in Central Nervous System Tumors: Opportunities and Challenges
Rui Zhang, Xueying Li, Si Zhang · 2024 · Microorganisms
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways
Signe K. Skadborg, Simone Bendix Maarup, Arianna Draghi, Annie Borch, Sille Hendriksen, Filip Oskar Mundt, Vilde Pedersen, Matthias Mann, Ib Jarle Christensen, Jane Skjøth-Ramussen et al. · 2024 · Cancer Immunology Research
Advancements in Telomerase-Targeted Therapies for Glioblastoma: A Systematic Review
Giovanni Pennisi, Placido Bruzzaniti, Benedetta Burattini, Giacomo Piaser Guerrato, Giuseppe Maria Della Pepa, Carmelo Lucio Sturiale, Pierfrancesco Lapolla, Pietro Familiari, Biagia La Pira, G D’Andrea et al. · 2024 · International Journal of Molecular Sciences
Contemporary strategies in glioblastoma therapy: Recent developments and innovations
Mariya Khan, Modassir Nasim, Mohammadamin Feizy, Rabea Parveen, Azka Gull, Saba M. Khan, Javed Ali · 2024 · Neuroscience
Leveraging TME features and multi-omics data with an advanced deep learning framework for improved Cancer survival prediction
Xuan Fan, Zihao He, Jing Guo, Dechao Bu, Dongchen Han, Xinchi Qu, Qihang Li, Sen Cheng, Aiqing Han, Jincheng Guo · 2025 · Scientific Reports
Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable
Radek Lakomý, Tomáš Kazda, Iveta Selingerová, Alexandr Poprach, Petr Pospíšil, Renata Belanová, Pavel Fadrus, Martin Smrčka, Václav Vybíhal, Radim Jančálek et al. · 2020 · Diagnostics
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
Julian S. Rechberger, Kendra A. Porath, Liang Zhang, Cody L. Nesvick, Randy S. Schrecengost, Jann Nagina Sarkaria, David J. Daniels · 2022 · Pharmaceutics
Allopregnanolone Promotes Migration and Invasion of Human Glioblastoma Cells through the Protein Tyrosine Kinase c-Src Activation
Carmen J. Zamora-Sánchez, Claudia Bello‐Alvarez, Mauricio Rodríguez‐Dorantes, Ignacio Camacho‐Arroyo · 2022 · International Journal of Molecular Sciences
Micro‐pillar array columns (µPAC): An efficient tool for comparing tissue and cultured cells of glioblastoma
Henriette Engen Berg, Skarphéðinn Halldórsson, Eris Aas Bakketeig, Bernd Thiede, Cecilie Jonsgar Sandberg, Elsa Lundanes, Einar Osland Vik-Mo, Steven Ray Wilson · 2022 · Journal of Chromatography Open
Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
Na Tosha Gatson, Jill S. Barnholtz‐Sloan, Jan Drappatz, Roger Henriksson, Andreas Felix Hottinger, Piet Hinoul, Carol A. Kruchko, Vinay K. Puduvalli, David Dinh Tran, Eric T. Wong et al. · 2021 · Frontiers in Oncology
Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma
Margaux Fresnais, Şevin Turcan, Dirk Theile, Johannes Ungermann, Yasmin Abou Zeed, Joshua Raoul Lindner, Marius Breitkopf, Jürgen Burhenne, Walter E. Haefeli, Rémi Longuespée · 2021 · Biomedicines
The University of California San Francisco Adult Longitudinal Post-Treatment Diffuse Glioma MRI Dataset
Brandon K.K. Fields, Evan Calabrese, John Mongan, Soonmee Cha, Christopher Paul Hess, Leo P. Sugrue, Susan Marina Chang, Tracy L. Luks, Javier E. Villanueva-Meyer, Andreas M. Rauschecker et al. · 2024 · Radiology Artificial Intelligence
Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1
Yang Liu, Yuan Feng, Lin Li Cheng, Yangxi Xu, Anhua Wu, Peng Cheng · 2025 · Cell Death and Disease
A deep learning model to predict glioma recurrence using integrated genomic and clinical data
Jessica Patricoski, Seema Nagpal, Ritambhara Singh, Jeremy Lyle Warner, Ece Dilber Gamsiz Uzun · 2025 · Communications Medicine
Brain tumors induce widespread disruption of calvarial bone and alteration of skull marrow immune landscape
Abhishek Dubey, Erika Yamashita, Biljana Stangeland, Imane Abbas, David Fooksman, Robert Adam Harris, Gregory M. Palmer, Wade R. Koba, Jinghang Zhang, Benjamin T. Himes et al. · 2025 · Nature Neuroscience
Sulforaphane Causes Cell Cycle Arrest and Apoptosis in Human Glioblastoma U87MG and U373MG Cell Lines under Hypoxic Conditions
Giulia Sita, Agnese Graziosi, Patrizia Hrelia, Fabiana Morroni · 2021 · International Journal of Molecular Sciences
Comparative efficacy and safety of therapeutics for elderly glioblastoma patients: A Bayesian network analysis
Binghao Zhao, Jiaming Wu, Yu Xia, Huanzhang Li, Yaning Wang, Tian Qu, Hao Xing, Yu Wang, Wenbin Ma · 2022 · Pharmacological Research
Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study
Peter Y. M. Woo, Tiffany H. P. Law, Kelsey K. Y. Lee, Joyce S W Chow, Lai‐Fung Li, Sarah S. N. Lau, Tony K. T. Chan, Jason M. K. Ho, Michael W. Y. Lee, Danny Tat Ming Chan et al. · 2023 · British Journal of Neurosurgery
Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma
Yuekun Wang, Shenglan Li, Yichen Peng, Wenbin Ma, Yu Wang, Wenbin Li · 2023 · Cancer Innovation
Bromodomain and Extraterminal Domain (BET) Protein Inhibition Hinders Glioblastoma Progression by Inducing Autophagy-Dependent Differentiation
Mayra Colardo, Deborah Gargano, Miriam Russo, Michele Petraroia, Daniele Pensabene, Giuseppina D’Alessandro, Antonio Santoro, Cristina Limatola, Marco Segatto, Sabrina Di Bartolomeo · 2023 · International Journal of Molecular Sciences